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Diet and exercise interventions in obese founder males improve the reproductive health of male 28 







Objective: To determine if dietary and exercise regimes in obese males can provide a novel 32 
intervention window for improving the reproductive health of the next generation. 33 
Design: Experimental animal study 34 
Setting: University research facilities 35 
Animal(s): C57BL6 male and female mice  36 
Intervention(s): Mice were fed a control diet (CD, 6% fat) or a high fat diet (HFD, 21% fat) for 9 weeks.  37 
After the initial feeding HFD males were allocated to diet and/or exercise interventions for a further 9 38 
weeks. Post intervention males were mated with females fed standard chow (4% fat) before and during 39 
pregnancy.   40 
Main Outcome Measures: F1 sperm motility, count, morphology, capacitation, mitochondrial function, 41 
and sperm binding and weight of reproductive organs.    42 
Results: Our primary finding was that diet intervention alone in founders improved offspring sperm 43 
motility and mitochondrial markers of sperm health (decreased ROS and mitochondrial membrane 44 
potential) ultimately improving sperm binding.  Sperm binding and capacitation was also improved in F1 45 
males born to combined diet and exercise intervention in founders. Founder sperm parameters and 46 
metabolic measures as a response to the diet and/or exercise, (i.e. lipid/glucose homeostasis, sperm 47 
count and morphology) correlated with offspring’s sperm function independent of founder treatment. 48 
This implicates paternal metabolic and reproductive status in predicting male offspring’s reproductive 49 
function. 50 
Conclusion: This is the first study to show that improvements to both metabolic (lipids, glucose and 51 
insulin sensitivity) and reproductive function (sperm motility and morphology) in obese fathers via diet 52 



















Peri-conception paternal health has been shown to influence the health of subsequent children. For 64 
example paternal smoking, age and occupational chemical exposure are associated with an increased 65 
risk of impaired child health (El-Helaly et al., 2011; Lee et al., 2009; Van Balkom et al., 2012). Recent 66 
epidemiological studies demonstrate that paternal nutritional status and obesity are correlated with 67 
altered child health outcomes (Danielzik et al., 2002; Li et al., 2009). However, human studies are 68 
confounded by the common environmental exposures shared by both father and child. 69 
 70 
Recent rodent models of paternal obesity have demonstrated that male offspring reproductive function 71 
was impaired, as evident by increased sperm intracellular reactive oxygen species (ROS), reduced 72 
sperm motility and reduced sperm binding (Fullston et al., 2012). Interestingly the same impairments 73 
persisted into second generation males (Fullston et al., 2012). The relevance of these findings are 74 
highlighted in western societies, as currently 70% of reproductive aged men are overweight or obese 75 
(2013) suggesting likely changes to offspring reproductive health. Therefore, lifestyle changes in obese 76 
men may provide an unappreciated novel intervention window to maximise the reproductive function of 77 
the next generation.  78 
 79 
Diet and exercise interventions in obese males have recently been shown to improve sperm 80 
parameters. Both gastric bypass surgery and weight loss through scheduled diet and exercise 81 
programs have resulted in improvements to sex hormone profiles, sexual function, total sperm count 82 
and morphology in men who lost the greatest amount of weight (Hakonsen et al., 2011; Reis et al., 83 
2012). The extent to which either the metabolic profile or adiposity enacted these outcomes remains to 84 
be investigated. In a mouse model of male obesity diet and exercise interventions normalised levels of 85 
sperm ROS, DNA damage and sperm binding (Palmer et al., 2012), parameters which subsequently 86 






Altogether the evidence highlights the potential of weight loss strategies to restore sperm function of 89 
obese males in both rodent models and humans.  To date no studies have determined whether weight 90 
loss and improved metabolic status in obese males can reverse the adverse reproductive effects in 91 
their male offspring. We therefore used our mouse model of male obesity to assess the hypothesis that 92 
a reduction in adiposity and/or an improvement to metabolic health via diet and exercise in obese 93 






MATERIALS AND METHODS 96 
Founder Animals and Diet 97 
Five week old male C57BL6 mice (n=40) were randomly assigned to one of two diets for an initial 98 
period of 9 weeks: 1) control diet (CD; n=8) (SF04-057; Specialty Feeds, Perth, Australia); or 2) a high 99 
fat diet (HFD; n=32) high in fat and nutrient matched (SF00-219; Specialty Feeds, Perth, Australia) 100 
(Supplementary Table 1). The HFD used in the study has been previously shown to increase adiposity 101 
and impair sperm function compared with the nutritionally matched CD (Bakos et al., 2011; Brake et al., 102 
2006; Mitchell et al., 2011; Palmer et al., 2011). After the initial feeding period, males allocated to the 103 
HFD were randomly allocated to one of the following interventions for a further 9 weeks: 1) continuation 104 
of a HFD (HH) (n=8); 2) change to a CD (HC) (n=8); 3) continuation of a HFD with exercise (HE) (n=8); 105 
4) change to a CD with exercise (HCE) (n=8). Mice allocated to the CD during the initial feeding period 106 
continued to be fed a CD during the intervention period as a baseline control (CC). The previously 107 
described swimming intervention regime simulates light exercise (Mcpherson et al., 2013; Palmer et al., 108 
2012) and demonstrated not to cause additional stress whereby the mice are given gradual 109 
acclimatisation to the full exercise program over two weeks (Palmer et al., 2012). Male body weights 110 
were recorded weekly both pre and post intervention. Metabolic status of founder males was obtained 111 
via fasted glucose tolerance test (GTT, expressed as area under curve (AUC)), fed insulin tolerance 112 
test (ITT, expressed as area above curve (AAC)) at 7 and 8 weeks respectively as per (Palmer et al., 113 
2012) and fasting post mortem plasma measures of cholesterol, free fatty acids (FFA), glucose and 114 
triglycerides as previously described in (Gatford et al., 2009).  Animals were individually housed in a 115 
12:12 h dark light cycle for the entire study, fed ad libitum and given free access to water. The use and 116 
care of all animals used in the study was approved by the Animal Ethics Committee of The University of 117 
Adelaide.  118 
 119 





At 7 weeks post intervention (21 weeks of age) founder males were paired with 2 normal weight 8-10 121 
week C57BL6 females for a maximum period of 8 nights. Female mice were housed with founder males 122 
during the dark cycle only and separated and maintained standard chow during the light cycle.  123 
Successful mating was assessed the following morning by the presence of a vaginal plug.  HH founders 124 
had a reduced number of successful matting’s compared with HCE and CC founders (p<0.05, data not 125 
shown). After successful mating female mice were group housed until day 15 of pregnancy and then 126 
individually housed until offspring were weaned. Females were maintained on standard chow during 127 
pregnancy and post birth. Females were allowed to pup and at weaning 1 male from each litter was 128 
randomly sampled for reproductive health measurements. For the CC group 8 F1 males were sampled 129 
from 8 litters representating 6 founders. For the HH group 10 F1 males were sampled from 10 litters 130 
representating 7 founders. For the HC treatment 10 F1 males were sampled from 10 litters 131 
representating 7 founders. For the HE treatment 10 F1 males were sample from 10 litters 132 
representating 7 founders and for the HCE treatment 8 F1 males were sampled from 8 litters 133 
representating 6 founders. F1 males were group housed independently of founder treatment and 134 
maintained on standard chow. 135 
 136 
Sperm Collection, Count, Motility and Morphology Analysis 137 
Sperm were collected immediately post mortem from the cauda epididymis and ductus deferens and 138 
expressed into 1 ml of G-IVF medium (Vitrolife, Gothenberg, Sweden) and incubated for at least 10 min 139 
in 6% CO2 and 5% O2 at 37oC (Bakos et al., 2011). Sperm count, motility and morphology were 140 
assessed blinded in accordance with WHO guidelines (Who & World Health Organisation, 2010), with 141 
at least 200 sperm from each sample measured. Sperm motility was assessed by classifying sperm as 142 
either progressive motile, non progressive motile or immotile. Motility was expressed as a percentage 143 
for both progressive motile and total motility (combination of both progressive motile and non 144 





(3:1) and stained with haematoxylin and eosin. Sperm morphology of individual sperm were scored as 146 
normal, tail defect or head defect as per (Palmer et al., 2012) and expressed as a percentage of each 147 
form.  148 
 149 
F1 Male Sperm Binding 150 
The numbers of sperm bound to the zona pellucida of an MII oocyte were assessed as described in 151 
(2011). At least 10 oocytes were analysed per sperm sample. 152 
 153 
F1 Male Sperm Capacitation and Acrosome Reaction 154 
Capacitation and acrosome reaction were measured using Arachis Hypogaea (peanut) agglutinin 155 
(Lectin PNA; Molecular Probes, Eugene, USA) as previously described (Baker et al., 2004; Bakos et al., 156 
2011).  A minimum of 200 sperm were counted per sample. The proportion of non-capacitated, 157 
capacitated and acrosome reacted sperm were expressed as a percentage. 158 
 159 
F1 Male Sperm Mitochondrial ROS assay & Vitality Measure 160 
The intracellular generation of mitochondrial ROS was determined using MitoSox Red (MSR; Molecular 161 
Probes, Eugene, USA) and SytoxGreen (Molecular Probes) as previously described (Koppers et al., 162 
2010). Both negative (sperm incubated only in SytoxGreen) and positive (sperm incubated in 1500 µM 163 
of H2O2) controls were conducted. MSR and SytoxGreen fluorescence was measured on a FACSCanto 164 
flow cytometer (BD Bioscience, North Ryde, Australia). Non-specific sperm events were gated out and 165 
20,000 cells were examined per sample. MSR results were expressed as percent of live sperm positive 166 
for MSR. Vitality was measured as the percentage of sperm that did not display SytoxGreen 167 
fluorescence. 168 
 169 





Sperm mitochondrial membrane potential was determined by using the ratiometric dye JC-1 (Molecular 171 
Probes, Eugene, USA) as previously described (2010). A negative control was also included whereby 172 
sperm were incubated in 10 µM of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) to dissipate 173 
membrane potential before incubation in JC-1. JC-1 and PI fluorescence were measured on a 174 
FACSCanto flow cytometer.  Non-specific sperm events were gated out and 20,000 cells were 175 
examined per sample. Results were expressed as the percent of live sperm positive for a high JC-1 176 
reading.  177 
 178 
Adiposity and Reproductive Organ Measurement 179 
Founder males at pre intervention week 9 (14 weeks of age) and post intervention week 8 (22 weeks of 180 
age) and 10 weeks of age for F1 male offspring, total adiposity was measured by a dual-emission X-ray 181 
absorptiometry machine (DEXA) (Piximus, Ge Lunar, Wisconsin, USA) as previously described (Nagy & 182 
Clair, 2000). At intervention week 9 (23 weeks of age) for founder males and 10 weeks of age for F1 183 
males gonadal fat, testes and seminal vesicles were dissected and weighed post mortem. All 184 




At intervention week 9 for founder males (23 weeks of age) and 10 weeks of age for F1 males, serum 189 
testosterone was measured by a stable-isotope dilution liquid chromatography coupled with tandem 190 
mass spectrometry as previously described (Bakos et al., 2011; Mcnamara et al., 2010). 191 
 192 
Statistics  193 
All data were expressed as mean ± SEM and checked for normality using a Kolmogorov-Smirnov test 194 





Version 18, SPSS Inc., Chicago, USA) with an observed power of ≥80%. A p value <0.05 was 196 
considered to be significant. 197 
Founder Measures 198 
Founder reproductive and metabolic changes were determined by a univariate general linear model. 199 
Cohort of animals and replicate were fitted as covariates 200 
F1 Male Measures 201 
To compare F1 male offspring sperm parameters, reproductive organs and testosterone levels across 202 
the 5 treatments, linear mixed effect models were fitted. In the model father ID was included as a 203 
random effect to adjust for dependence in results between offspring from the same father and litter size 204 
as a dependent variable to compared litter size variations between and within the 5 treatments.  205 
Correlations between F1 male offspring reproductive health and founder metabolic and reproductive 206 







Effect of Diet and Exercise on Founder Metabolism and Sperm Parameters 210 
Founders fed a HFD during the pre-intervention period had a 20.4% increase in body weight compared 211 
with founders fed a control diet (31.6 ± 0.69 vs. 26.3 ± 0.47, p<0.05). Post intervention CC, HH and HE 212 
founders continued to gain weight (13.6%, 15.8% and 6.4% respectively, Table 1), while interventions 213 
involving diet (HC and HCE) reduced founder body weight (-4.4% and -11.0% respectively, Table 1). 214 
Founder male post-intervention metabolic and reproductive phenotypes recapitulated previous findings 215 
(Mcpherson et al., 2013; Palmer et al., 2012). Diet interventions (HC and HCE) reduced adiposity (total 216 
and gonadal), serum cholesterol and glucose tolerance compared with HH founders (p<0.05, Table 1). 217 
Founders who received exercise intervention alone (HE) maintained their increased serum cholesterol 218 
and insulin resistance (Table 1) while sustaining their pre intervention level of adiposity such that is was 219 
still increased compared with CC founders (p<0.05, Table 1), however reduced compared with HH 220 
founders (p<0.05, Table 1). Interventions including exercise (HE and HCE) improved glucose clearance 221 
compared with HH founders (p<0.05, Table 1) with HE founders also reducing fasting glucose (p<0.05, 222 
Table 1).  All interventions reduced the number of sperm with tail defects compared with HH founders 223 
(p<0.05, Table 1) while exercise interventions in founders (HE and HCE) additionally restored sperm 224 
motility (p<0.05, Table 1). Diet intervention alone also increased serum testosterone levels compared 225 
with HH founders (p<0.05, Table 1) restoring it to levels of CC founders. 226 
 227 
Effect of Founder Diet and Exercise on F1 Conventional Sperm Parameters 228 
HH founders produced F1 males with reduced progressively motile sperm compared with males born to 229 
CC founders (p<0.05, Table 2). Diet intervention alone in founders (HC) increased the percentage of 230 
progressively motile sperm in F1 males compared with F1 males born by HH founders (p<0.05, Table 231 
2), restoring to level that of F1 males born by CC founders while exercise interventions in founders with 232 





F1 males (Table 2). There was no change in the total proportion of motile sperm or proportion of 234 
immotile sperm from F1 males born from any founder treatment group (Table 2). Founder treatment 235 
group had no effect on the proportion of normal sperm morphology in F1 males (Table 2), although the 236 
proportion of head and tail defects in sperm were altered among groups (p<0.05, Table 2). HH founders 237 
produced F1 males with reduced sperm counts compared with F1 males born by CC founders (p<0.05, 238 
Table 2). There were no significant improvements to F1 sperm count from diet and/or exercise 239 
interventions in founders compared with F1 male born by HH founders (Table 2). 240 
 241 
Effect of Founder Diet and Exercise on F1 Sperm Capacitation and Oocyte Binding  242 
HH founders did not produce F1 males with any difference in sperm capacitation compared with CC 243 
founders (CC), concordant with previous reports using shorter feeding periods (Fullston et al., 2012). 244 
However, all diet and/or exercise interventions in founders (HC, HE and HCE) increased the 245 
percentage of capacitated F1 sperm compared with F1 males born to HH or CC founders (p<0.05, 246 
Table 2), conversely reducing non capacitated and acrosome reacted sperm (Table 2).  247 
 248 
HH founders produced F1 males with reduced sperm binding compared with F1 males born to CC 249 
founders (p<0.05, Table 2). Diet intervention with (HCE) or without (HC) exercise in founders increased 250 
sperm binding compared with F1 males born from HH founders (p<0.05, Table 2) with F1 males born to 251 
combined diet and exercise (HCE) intervention in founders exceeding numbers of F1 males born by CC 252 
founders (p<0.05, Table 2). In contrast, exercise alone intervention (HE) in founders did not improve 253 
sperm binding in F1 males compared to born to HH founders (p>0.05, Table 2).  254 
 255 





There was no effect of HH founders on F1 levels of sperm ROS compared with F1 males born to CC 257 
founders, which was previously reported in shorter feeding periods (Fullston et al., 2012). Diet 258 
intervention alone in founders (HC) reduced MSR positive sperm in F1 males compared with F1 males 259 
born from CC, HE and HCE founders (p<0.05, Table 2). Once more a founder intervention limited solely 260 
to diet (HC) reduced the proportion of F1 sperm positive for high JC1 compared with F1 males born to 261 
HH, and HCE founders (p<0.05, Table 2), while exercise intervention alone (HE) had no effect (Table 262 
2).  263 
 264 
Effect of Founder Diet and Exercise on F1 Male Reproductive Body Composition and Serum 265 
Testosterone 266 
There was no effect of founder treatment on F1 male body composition as assessed by total body 267 
weight, total adiposity, gonadal adiposity, seminal vesicle weights, testes weights or serum testosterone 268 
concentration (p>0.05, Table 3). However, it must be noted that the similarities in testosterone results in 269 
offspring to that of their fathers was further confirmed by founder serum testosterone positively 270 
correlating with offspring serum testosterone (0.693, p<0.001, Table 4).  271 
 272 
Correlations of Founder Adiposity and Metabolic status with F1 Reproductive Function 273 
We have previously shown that founder metabolites independent to treatment group correlated with 274 
founder male sperm function, embryo development and early fetal health markers (Mcpherson et al., 275 
2013; Palmer et al., 2012) with perturbed sperm function seen in F1 males produced by founders with 276 
increased adiposity and serum cholesterols (Fullston et al., 2012). Given the variations of founder 277 
metabolites within treatments, the varied improvements to F1 male sperm parameters across 278 
treatments and the systematic changes to whole body physiology from obesity impacting on 279 
spermatogenesis (i.e. hyperglycaemia) we further examined if measures of founder metabolic health 280 





and metabolic health in founders both between and within treatment groups could help explain their 282 
son’s reproductive measures. Correlations highlighted that F1 male reproductive health (sperm motility, 283 
sperm binding, sperm count, total body weight, testes weights, seminal vesicle weights, gonadal 284 
adiposity and testosterone levels) is sensitive to founder gonadal adiposity, serum 285 
FFA/triglyceride/cholesterol concentrations, glucose tolerance and insulin sensitivity (p<0.05, Table 4). 286 
 287 
Correlations of Founder Reproductive Function with F1 Reproductive Function 288 
Commonly observed sub-fertility phenotypes seen in obese men, such as reduced sperm motility, count 289 
and morphology have been associated with chromatin and epigenetic modifications in sperm 290 
(Hammoud et al., 2011; Iranpour et al., 2000). We hypothesised that sperm parameters in founders 291 
may indicate epigenetic modifications in sperm which might form the basis for their offspring inheriting 292 
similar sub fertility phenotypes. Correlations revealed that an F1 male’s reproductive measures are also 293 
sensitive to a founder male’s reproductive health (Table 4). For example founder sperm levels of normal 294 
morphology correlated positively with F1 testes weights (p=0.04) and negatively with F1 sperm positive 295 







To date the end points for assessing the reversibility of paternal obesity and associated co-morbidities 299 
have been limited to hormone profiles (Bastounis et al., 1998; Hammoud et al., 2009; Strain et al., 300 
1988), sperm function (Hakonsen et al., 2011; Reis et al., 2012) and extended as far as early embryo 301 
development and quality in rodent models of paternal obesity (Mcpherson et al., 2013). This is the first 302 
study to further determine if the altered reproductive phenotypes in male offspring that results from an 303 
obese father can be improved by lifestyle interventions. We demonstrate that diet and/or exercise 304 
interventions in obese fathers can improve the reproductive health of male offspring in a mouse model, 305 
demonstrating that adiposity, metabolic and reproductive status of fathers influences their son’s 306 
reproductive health. If translatable to the human this data suggests a potential novel pre-conception 307 
intervention window for obese fathers to improve their male offspring’s reproductive health via lifestyle 308 
interventions. 309 
 310 
Sperm motility and concentration are standard parameters for assessing male fertility (2010). While 311 
additional measures of sperm capacitation and binding (Franken & Oehninger, 2006; Liu et al., 2004) 312 
can be indications of sperm function, due to the essential nature of these processes for penetration into 313 
the oocyte during fertilisation (Johnson & Everitt, 2000). Further, sperm ROS concentrations are a 314 
further marker of sperm health with increased levels in human sperm correlating with reduced 315 
fertilisation, impaired embryonic development and pregnancy loss (Dada et al., 2010; Gharagozloo & 316 
Aitken, 2011; Tunc et al., 2010; Zribi et al., 2011).  317 
 318 
In a mouse model, it has been previously reported that in addition to effects on founder male sperm, 319 
male offspring born from HFD fathers also had reduced sperm motility, reduced sperm binding and 320 





sperm binding of male offspring born from HFD (HH) fathers, although we did not report similar 322 
increases in levels of ROS.  This could be due to a number of reasons including duration of founder 323 
exposure to diet (10 weeks vs. 18 weeks) or different ROS detection method (DCFDA vs. MitoSox Red) 324 
which may explain the differences.  325 
 326 
Diet intervention alone in obese founders restored adiposity, glucose homeostasis and cholesterol 327 
levels similar to human studies (Klop et al., 2013). These founders produced male offspring with 328 
improvements to sperm mitochondrial health (ROS and membrane potential) which were sometimes 329 
below levels of controls (CC), increased sperm motility, binding and capacitation compared with F1 330 
males born to HH founders. This suggests that simple caloric restriction in obese males restores 331 
adiposity as well as glucose/lipid metabolism and can improve subsequent male offspring sperm 332 
function, which would potentially increase embryo development and pregnancy rates for this F1 333 
generation. Combined diet and exercise interventions (HCE) in founders also increased the functional 334 
measure of sperm binding in their male offspring likely resulting from increased sperm capacitation and 335 
improvements to sperm motility which again suggests likely improvements to fertilisation. 336 
 337 
Interestingly, the continuation of a HFD with an exercise intervention in founders (HE) showed the least 338 
improvements to offspring sperm function, with only slight improvements to sperm capacitation 339 
compared with F1 males from HH founders. Founder males in this group, maintained their pre 340 
intervention level of adiposity compared with founders undergoing diet interventions (HC or HCE) and 341 
controls (CC), indicating that the exercise regime saw the similar amount of calories expended as was 342 
ingested. HE founders also maintained their increased serum cholesterols likely resulting from the lipid 343 
dense diet consumed. This is a similar phenotype to that observed in exercise intervention alone  in 344 





Lindgren et al., 2013). This implies that improvements to these aspects of sperm function in male 346 
offspring maybe related to the adipose state and cholesterol levels of their father.  347 
 348 
Increased scrotal heat due to increased adiposity in humans is associated with reduced sperm motility, 349 
morphology, increased sperm DNA damage and increased sperm oxidative stress (Paul et al., 2008a; 350 
Paul et al., 2008b; Shiraishi et al., 2010), parameters which have been independently linked with 351 
epigenetic changes to sperm (Hammoud et al., 2011; Iranpour et al., 2000; Tunc & Tremellen, 2009). 352 
Therefore as our males fed a HFD with (HE) maintain gonadal adiposity, increased scrotal heat could 353 
potentially underpin the transmission of altered offspring health seen. However, it should be noted that 354 
offspring from males fed a HFD with exercise (HE) interventions did have some improvements in sperm 355 
function (motility and morphology), suggesting that heat may not be the sole mechanism for the 356 
adverse changes to offspring sperm function seen in the current study. 357 
 358 
The precise mechanisms that are responsible for the transmission of altered offspring health due to 359 
paternal obesity remain unidentified. Epigenetic, molecular and functional changes within the sperm 360 
either through changes to epigenetic marks to sperm DNA and sperm chromatin structure are clearly 361 
implicated. Direct insults to founder male sperm DNA such as irradiation induced sperm DNA damage, 362 
or gamete and somatic cell DNA damage induced by impaired intra-uterine environments from mothers 363 
(Adiga et al., 2010) leads to impaired reproductive function (Fullston et al., 2012) and changes to body 364 
composition in first generation offspring (Dunn & Bale, 2011). This links the molecular composition of 365 
father’s sperm at the time of conception to the health of the next generation.  There is emerging 366 
evidence that increased adiposity in males impacts the epigenetic status of their sperm. Correlations 367 
with markers of founder metabolic health and offspring sperm function determined that founder gonadal 368 





progressive motile sperm independent of treatment group. Global measures of methylation in testes 370 
and elongating spermatids showed that DNA from cells were hypomethylated in obese male mice 371 
(Fullston et al., 2013). Obesity additionally alters the methylation status of DNA in other tissues (Barres 372 
& Zierath, 2011). Whether the changes to reproductive function in our male offspring results from a 373 
global alteration to de novo methylation or site specific methylation at paternally imprinting gene loci in 374 
the obese father’s sperm, remains to be determined. Sperm also harbour a vast array of small non-375 
coding RNAs which are thought to be important for early embryo and fetal development (Liu et al., 376 
2012) and have been previously shown to be altered in sperm of obese rodents (Fullston et al., 2013). 377 
Interestingly, changes to circulating serum microRNAs caused from obesity were restored through 378 
weight loss (Ortega et al., 2013) providing evidence that interventions to health can change the 379 
microRNA content of specific tissues. Whether the diet interventions (HC and HCE) which induced 380 
weight loss could also restore the microRNA content of testes and sperm and identify a potential part of 381 
the mechanism that might improve reproductive function in offspring remains to be determined.  382 
 383 
We have previously demonstrated that metabolic markers in fathers including plasma lipids, glucose 384 
homeostasis and insulin sensitivity can impact on both their sperm function and F1 embryo 385 
development independently of adiposity (Mcpherson et al., 2013; Palmer et al., 2012). In this study, 386 
founder plasma measures of glucose, insulin and fatty acid metabolism which showed the biggest 387 
restoration in diet interventions displayed the strongest correlations with male offspring sperm function 388 
and body composition including total body weight, testes and seminal vesicle weights.  Increased 389 
circulating levels of serum lipids in men, have been associated with increased ROS in sperm (Koppers 390 
et al., 2010) and changes to the global methylation of sperm DNA (Tunc & Tremellen, 2009).  391 
Additionally fasting plasma insulin concentrations in fathers can predict umbilical cord insulin levels and 392 
therefore offspring fetal size (Shields et al., 2006). Together these data suggest that pre-conception 393 





phenotypes thereby providing part explanations for our correlations between markers of paternal 395 
metabolic state with their son’s reproductive phenotypes. 396 
 397 
Recently it has been demonstrated that the proteomic, mRNA and microRNA content of sperm/testes 398 
are altered in obese rodents (Daxinger & Whitelaw, 2012; Fullston et al., 2013; Ghanayem et al., 2010; 399 
Kriegel et al., 2009; Palmer et al., 2011; Youngson & Whitelaw, 2011). In agreement with our previous 400 
study (Palmer et al., 2012), we report here that diet and exercise interventions in founders improves 401 
their sperm function, suggesting lifestyle interventions may at least in part restore the micro-molecular 402 
environment of testes and/or epididymis thereby restoring the molecular makeup of sperm. The concept 403 
that diet and exercise interventions restore the micro-environments of reproductive organs and 404 
therefore restores the molecular determinants responsible for programming offspring health in sperm is 405 
supported by the associations of founder sperm parameters of morphology, count and motility with F1 406 
reproductive parameters of sperm morphology, capacitation, testes weights and serum testosterone 407 
levels. 408 
 409 
The model described of feeding a HFD to induce obesity mimics some aspects of human obesity 410 
including increased adiposity serum cholesterol and altered glucose and insulin homeostasis (Klop et 411 
al., 2013), with diet and exercise interventions used previously shown to restore sperm function and 412 
DNA integrity (Palmer et al., 2012), similar to those reported improvements to sperm parameters found 413 
in diet and exercise interventions in human studies (Hakonsen et al., 2011). Due to the similar 414 
metabolic and sperm function phenotypes of both rodent models of obesity and obese humans with diet 415 
and exercise interventions suggests that the changes and or improvements to the testicular 416 
microenvironment is likely similar and therefore the molecular changes proposed to founder sperm to 417 





humans. However the differences in sperm molecular makeup between both mouse and humans still 419 
need to be noted. For example it has been proposed that human sperm are much more sensitive to 420 
environmental perturbations than mouse sperm due to their higher levels of histone retention (~15% 421 
human (Gatewood et al., 1987) compared with ~1% in the mouse (Balhorn et al., 1977)) which are 422 
capable of normal histone modifications (Farthing et al., 2008) and are retained at loci that contain 423 
genes important for early embryogenesis (Farthing et al., 2008). The similarities between both human 424 
and rodent models of male obesity suggest that these results would likely be translatable to humans; 425 
however confirmation studies in a human cohort would still be warranted.  426 
 427 
This report shows that impaired offspring reproductive health resulting from paternal obesity can be 428 
improved through weight loss and restoration of metabolic health in fathers via diet interventions. 429 
Additionally paternal markers of adiposity, metabolism and reproductive function may also indicate their 430 
son’s reproductive function, thus potentially highlighting a novel intervention window for improving 431 
reproductive health outcomes in the next generation. The direct sperm molecular mechanism 432 
responsible for this improvement transmitted via the father and if this can be replicated in humans to 433 
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Table 1:  Effect of Diet and Exercise on Founder Adiposity, Serum Metabolites and Reproductive Measures 
 
Data is representative of 8 founder males per treatment group with sperm morphology representative of 4 founder males per treatment group and expressed per male. Testes 
weights were a combined weight of both left and right testis.  Data was analysed by a GLM with cohort and replicated fitted as covariates. Different letters denote significance 
at p<0.05.   
 Diet/Intervention 
 CC HH HC HE HCE 
Pre intervention      
Body weight (g) 26.3 ± 0.47a 31.5 ± 0.82b 31.8 ± 1.5b 30.8 ± 1.3b 32.6 ± 1.9b 
Total adiposity  (% of body weight) 14.6 ± 0.92a 24.7 ± 1.7b 24.7 ± 2.0b 24.5 ± 1.7b 26.0 ± 1.6b 
Post intervention      
Final body weight (g) 29.9 ± 0.58a 36.3 ± 1.14b 30.4 ± 1.6a 32.8 ± 1.2a 29.2 ± 1.1a 
Total adiposity  (% of body weight) 16.4 ± 0.88a 28.4 ± 2.00b 18.1 ± 2.15a  24.0 ± 1.19c 16.8 ± 1.18a 
Gonadal Adiposity (% total body weight) 2.46 ± 0.2a 4.82 ± 0.28b 2.82 ± 0.27a 4.06 ± 0.27c 2.77 ± 0.28a 
Glucose (mmol/L) 10.0 ± 0.51ab 10.6 ± 0.42a 9.8 ± 0.47ab 9.4 ± 0.48b 9.7 ± 0.44ab 
Cholesterol (mmol/L) 3.24 ± 0.36ac 4.11 ± 0.30b 3.17 ± 0.34ac 3.82 ± 0.34ab 2.39 ± 0.36c 
FFA (mmol/L) 0.69 ± 0.05a 0.64 ± 0.04ab 0.61 ± 0.04ab 0.65 ± 0.04ab 0.55 ± 0.05b 
Triglycerides (mmol/L) 0.77 ± 0.06 0.83 ± 0.05 0.78 ± 0.06 0.83 ± 0.06 0.80 ± 0.06 
Glucose (AUC) 1797 ± 122a 2111 ± 100b 1814 ± 123a 1695 ± 113a 1787 ± 103a 
Insulin (AAC) 167 ± 13.4a 121 ± 10.1b 135 ± 12.2ab 75 ± 12.4c 111 ± 12.2b 
Reproductive Measures      
Testosterone (ng/L) 0.36 ± 0.14a 0.10 ± 0.03b 0.38 ± 0.15a 0.28 ± 0.11ab 0.17 ± 0.04ab 
Testes weights (g) 0.16 ± 0.05 0.17 ± 0.04 0.16 ± 0.04 0.16 ± 0.03 0.16 ± 0.05 
Seminal vesicle weights (g) 0.37 ± 0.03 0.39 ± 0.03 0.36 ± 0.02 0.34 ± 0.03 0.36 ± 0.03 
Sperm count (106) 21.7 ± 3.1 20.0 ± 3.3 16.9 ± 3.1 22.2 ± 2.9 22.1 ± 3.3 
Progressive sperm motility (%) 31.9 ± 5.7 26.2 ± 6.1 28.9 ± 5.7 38.6 ± 5.3 39.8 ± 6.1 
Total sperm motility (%) 71.3 ± 3.9a 58.3 ± 4.2b 66.6 ± 3.9ab 74.5 ± 3.6a 72.9 ± 4.2a 
Sperm normal forms (%) 56.9 ± 1.8a 55.9 ± 3.1a 59.3 ± 1.9ab 64.1 ± 2.2b 58.7 ± 3.7ab 
Sperm with tail defects (%) 30.8 ± 2.1a 36.4 ± 3.0b 29.9 ± 1.3a 29.7 ± 2.7a 30.7 ± 2.5a 
Sperm with head defects (%) 12.2 ± 2.4a 8.6 ± 1.9ab 10.6 ± 1.1ab 6.1 ± 0.7b 10.51 ± 0.7ab 
Table 2: Effect of Founder Diet and Exercise on F1 Sperm Function 
 Founder Diet/Intervention 
F1 Sperm Measures CC HH HC HE HCE 
Conventional Sperm Parameters      
Progressive sperm motility (%) 32.2 ± 6.4a  18.1 ± 5.1b 31.2 ± 6.0a 22.1 ± 6.0ab 23.0 ± 5.6ab 
Total sperm motility (%) 53.1 ± 5.2 45.9 ± 4.3 49.2 ± 4.9 45.6 ± 4.6 46.9 ± 4.4 
Immotile sperm (%) 48.1 ± 4.7 54.5 ± 3.7 48.6 ± 4.7 56.7 ± 4.3 54.6 ± 4.1 
Sperm normal morphology (%) 56.7 ± 4.3 50.6 ± 3.6 50.7 ± 4.1 51.8 ± 4.0 49.1 ± 3.7 
Sperm head defect (%) 10.8 ± 1.5ab 11.6 ± 1.3ab 14.8 ± 1.5a 9.4 ± 1.4b 10.4 ± 1.3b 
Sperm tail defect (%) 32.3 ± 3.4a 37.7 ± 2.8ab 34.4 ± 3.3ab 38.6 ± 3.2ab 40.4 ± 2.9b 
Sperm count (106) 12.3 ± 1.1a 10.0 ± 0.9b 11.1 ± 1.2ab 8.2 ± 1.0b 10.2 ± 1.1ab 
Sperm Capacitation and Oocyte 
binding 
     
Sperm non capacitated (%) 2.36 ± 0.38ab 3.04 ± 0.30a 2.05 ± 0.34b 1.54 ± 0.31b 1.27 ± 0.33b 
Sperm capacitated (%) 94.3 ± 0.6a 94.6 ± 0.5a 96.5 ± 0.6b 96.2 ± 0.5b 96.6 ± 0.6b 
Sperm acrosome reacted (%) 3.33 ± 0.39a 2.35 ± 0.25ac 1.42 ± 0.28bc 2.24 ± 0.26c 2.12 ± 0.64c 
Sperm bound to MII oocyte 48.0 ± 1.2a 37.6 ± 1.3b 42.9 ± 1.5c 40.7 ± 1.2bc 52.9 ± 1.5d 
Sperm Mitochondrial Function      
Sperm positive for MSR (%) 61.3 ± 4.3a 57.1 ± 3.6ab 49.6 ± 4.0b 60.5 ± 4.0a 60.8 ± 3.6a 
Vitality (%) 58.8 ± 4.9 60.7 ± 4.1 65.5 ± 4.6 63.0 ± 4.3 56.9 ± 4.1 
Sperm positive for high JC1 (%) 52.4 ± 4.1ab 55.6 ± 3.4a 48.1 ± 3.8b 51.3 ± 3.8ab 60. 3 ± 3.3a 
 
8 F1 CC and HCE males and 10 HH, HC and HE males were analysed and expressed per animal representative of 6 CC and HCE founders and 7 HH, HC and HE founders. 
MSR H2O2 positive control was 73.4% and MSR negative control was 4.5%.  CCCP negative control for high JC1 was 17.1% and PI only negative control for high JC1 was 
2.7%. Data was analysed by a linear mixed effects model with father ID added as a random effect and litter size as a fixed variable. Different letters denote significance at 
p<0.05.  
 Table 3:  Effect of Founder Diet and Exercise on F1 Male Reproductive Organs and Testosterone 
 Founder Diet/Intervention 
F1 weight CC HH HC HE HCE 
Total body weight (g) 22.0 ± 0.3 22.1 ± 0.3 21.8 ± 0.3 21.3 ± 0.3 22.7 ± 0.3 
Total adiposity (g) # 1.65 ± 0.06 1.57 ± 0.07 1.51 ± 0.07 1.51 ± 0.06 1.53 ± 0.06 
Gonadal adiposity (g)# 0.146 ± 0.016 0.152 ± 0.014 0.158 ± 0.016 0.168 ± 0.015 0.145 ± 0.016 
Testes (g)# 0.145 ± 0.003 0.155 ± 0.003 0.154 ± 0.003 0.149 ± 0.003 0.153 ± 0.003 
Seminal Vesicles (g)# 0.149 ± 0.010 0.155 ± 0.009 0.42 ± 0.011 0.150 ± 0.010 0.165 ± 0.010 
Testosterone (ng/L) 0.167 ± 0.061 0.109 ± 0.054 0.166 ± 0.066  0.112 ± 0.073 0.114 ± 0.057 
 
8 F1 CC and HCE males and 10 F1 HH, HC and HE males were analysed and expressed per male representative of 6 CC and HCE founders and 7 HH, HC and HE founders. 
Testes weights were a combined weight of both left and right testis. #No significant differences in total or gonadal adiposity, testes or seminal vesicle weights when expressed 
as percentage of total body weight. Data was analysed by a linear mixed effects model with father ID added as a random effect and litter size as a fixed variable.   
Table 4: Founder Metabolic and Reproductive Health Correlate with F1 Reproductive Measures 




Sperm Function    
Progressive sperm motility 
(%) 
FFA (mmol/L) -0.557 0.024 
Non progressive sperm 
motility (%) 
Gonadal adiposity (%) 0.489 0.045 
Sperm head defect (%) Sperm count (106) -0.539 0.029 
Sperm positive for MSR (%) 
Progressive sperm motility (%) 
Total motile sperm (%) 
Sperm normal morphology (%) 






















Sperm non capacitated (%) 
Progressive sperm motility (%) 
Total motile sperm (%) 







Sperm capacitated (%) 
Progressive sperm motility (%) 
Total motile sperm (%) 







Sperm acrosome reacted 
(%) 
Sperm count (106) 0.693 0.006 
Sperm count (106) 
FFA (mmol/L) 
Triglycerides (mmol/L) 
Gonadal adiposity (%) 
Progressive sperm motility (%) 











Reproductive Organs and 
Testosterone 
   
Total body weight (g) 
Glucose (mmol/L) 
Glucose (AUC) 










Progressive sperm motility (%) 









Seminal vesicles (g) 
Glucose (mmol/L) 
Glucose (AUC) 















Sperm normal morphology (%) 








Correlations were determined by multiple regression analysis and corrected for multiple observations.  





Harlan Teklad TD88137 Equival 
Sucrose (g/100g) 34.1 34.1 
Casein (Acid) (g/100g) 19.5 19.5 
Canola Oil (g/100g) 6.0 - 
Clarified Butter (g/100g) - 21.0 
Cellulose (g/100g) 5.0 5.0 
Wheat starch (g/100g) 30.5 15.5 
Minerals (g/100g) 4.9 4.9 
Digestible energy (MJ/kg) 16.1 19.4 
Digestible energy from 
lipids (%) 
21.0 40.0 
Digestible energy form 
protein (%) 
14.0 17.0 
Digestible energy from 
carbohydrates (%) 
65.0 43.0 
CD = Control diet (6% fat) and HFD = high fat diet (21% fat).  
 
